Price Move History
- Daily moves over 5%
- 94 192 sessions, December 31, 2021 to October 5, 2022
- Largest daily move
- -34.4% close of April 18, 2022
- 1-month change
- +16.2% closing prices, September 2, 2022 to October 5, 2022
Company Description
LadRx (OTC: CYTR) is classified in the biotechnology industry within the Healthcare sector.
CYTR declined 81.8% in the year to October 5, 2022. The last closing price was $0.0920.
This page collects what Stock Titan holds for CYTR, including price data and latest news.
Stock Performance
LadRx (CYTR) closed at $0.0920 on October 5, 2022. In the year to October 5, 2022, the price lost 81.8%.
CYTR Metrics & Rankings
Price returns through October 5, 2022. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
LadRx has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, partnership. View all CYTR news →
SEC Filings
CYTR Company Profile & Sector Positioning
LadRx (CYTR) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing CYTR often look at related companies in the same sector, including Vertex Pharmaceuticals Inc (VRTX), Regeneron Pharmaceuticals Inc (REGN), Moderna, Inc. (MRNA), argenx SE (ARGX), and BeOne Medicines Ltd. (ONC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CYTR's relative position within its industry.